Beautiful Bahamas welcomes revolutionary blood sugar management supplement, Lysulin, as it makes its grand entrance into the Caribbean market through an exciting partnership with Florida Food Group. This strategic collaboration aims to expand the distribution of Lysulin’s groundbreaking products, empowering individuals with prediabetes and type 2 diabetes to achieve better glycemic control and healthier A1c levels.
Lysulin has garnered widespread attention for its patent-pending formula, combining lysine, zinc, and vitamin C, which has demonstrated remarkable potential in aiding individuals with high blood sugar levels to lead active and vibrant lives. Through rigorous double-blind placebo-controlled studies, the supplement has proven effective in helping people manage their blood sugar levels by targeting the process of protein glycation, the root cause of diabetic complications.
The mastermind behind Lysulin is Dr. John Burd, a distinguished scientist and former CEO of Dexcom, Inc., a leading Continuous Glucose Monitoring Systems company. Dr. Burd’s profound dedication to helping family members and countless others inspired him to delve into the crucial area of managing blood sugar levels, leading to the creation of Lysulin – a life-changing product for many.
William Armstrong, the owner of Florida Food Group, brings a wealth of experience as a long-term importer of nutrition and food items into the Bahamas. Known for distributing high-quality products throughout the islands, including Freeport and all the major regions, Florida Food Group is excited to add Lysulin to its portfolio. With a strong presence in grocery stores, drug stores, and airports, Florida Food Group is well-positioned to introduce Lysulin to a wide audience in the Bahamas.
“We are gratified by the feedback we receive every day from people who tell us that Lysulin has made a real difference in their lives, and we believe it can make a positive difference in yours as well,” said Dr. John Burd, the founder of Lysulin.
The partnership between Lysulin and Florida Food Group marks a significant step forward in addressing the global health challenge of diabetes. Together, they are committed to providing individuals with accessible and clinically supported products that harness the power of nature to control blood sugar levels.
Lysulin’s expansion into the Caribbean market includes its product line featuring five options: Lysulin Capsules, Chewable Tablets, Once-a-Day Powder, Liquid, and delicious Chocolate and Vanilla Shakes. With a firm commitment to educating individuals about blood sugar control through diet and exercise, Lysulin aims to provide affordable, convenient, and scientifically supported products containing powerful ingredients found in nature.
“We are excited to bring Lysulin to the Caribbean. This is just the next major step for us,” expressed Dr. John Burd, the visionary behind Lysulin.
As Lysulin prepares to debut in the Bahamas and the Caribbean, both companies are thrilled about the potential positive impact on the health and well-being of the people in the region. By offering scientifically formulated supplements and fostering awareness about blood sugar control, Lysulin continues to revolutionize how people manage their health and live fulfilling lives.
For more information about Lysulin and its products, please visit www.lysulin.com.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Lysulin, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
About Lysulin, Inc.
Lysulin was founded by Dr. John Burd, a renowned scientist and the founder and former CEO of Dexcom, Inc., the leader in Continuous Glucose Monitoring Systems. His current research is focused on the toxic sugar coating that happens when excess glucose binds to and changes proteins in our bloodstream, a process called “protein glycation.”